Resources

This brief provides an overview of program-based budgeting and associated performance frameworks, and advice on choosing oxygen-related indicators to include in program-based budgets. The content within this brief is general in nature and, in order to be implemented, will require adaptation to specific health systems based on their particular budget and health system structure. This document draws heavily on both the World Health Organization’s work on program-based budgeting, and PATH’s efforts on medical oxygen.

The digital directory of technologies for noncommunicable diseases and mental health in Asia-Pacific, developed by PATH under the Asian Development Bank’s guidance, aims to identify and catalog cost–effective, patient–centric technology innovations suitable for primary health care (PHC) settings.This directory focuses on screening, diagnosis, monitoring, and management of noncommunicable diseases (NCDs) and mental health conditions in low- and middle-income countries. By providing a comprehensive repository of scalable health technologies, the initiative seeks to enhance accessibility and affordability of care, particularly in rural and underserved areas, making PHCs more effective as the first point of contact for individuals.The directory serves as a searchable resource for stakeholders and external audiences, showcasing market–ready technologies for NCD and mental health care in the Asia–Pacific region. The development process involved thorough searches using specialized keywords on platforms like Google Scholar, Tracxn, Crunchbase, and Pitchbook, ensuring technologies met criteria for affordability, durability, ease of use, maintenance, and power requirements.Technologies are classified under major NCD categories (diabetes, chronic respiratory diseases, cardiovascular diseases, and cancer) and mental health diseases, with further categorization by diagnostic tools, digital diagnostics, AI/ML innovations, telemedicine platforms, e–referral tools, and labor–saving technologies.

Nanopore–based sequencing platforms offer the potential for affordable malaria molecular surveillance in resource–limited settings to track and ultimately counteract emerging threats, such as drug resistance and diagnostic escape.With support from the Bill and Melinda Gates Foundation and building on the success of NOMADS, NOMADS 2 is continuing to strengthen and expand the use of nanopore sequencing for malaria genomic surveillance.This factsheet provides an overview of the NOMADS 2 project.

This publication was prepared by the staff of the African Union Development Agency (AUDA-NEPAD) and PATH, with technical support from the Medicines Policy and Regulatory Reforms Technical committee and other external contributions. This document is meant to be used as a training guide on regulatory systems strengthening in Africa for National Medicines Regulatory Authorities, Regional Economic Communities and all other stakeholders directly or indirectly working in, or able to influence and support regulatory systems at country, regional or continental level.

Smartphone sensor–enabled health measurement, as part of medical device technologies, is rapidly progressing from theory to practice, therefore utilizing comprehensive health datasets to train and validate artificial intelligence (AI) models for digital health applications.There is a critical gap in the reach of medical devices in low–resource settings where supply of basic health technologies like pulse oximeters, hemoglobinometers, and patient monitors do not meet clinical demand, while many companies prioritize wellness products for high–income populations. A strong need exists to strengthen the innovation ecosystem to allow AI researchers to externalize algorithms more easily to deliver public health products faster, specifically for solutions intended for use by health care providers in low–resource clinical settings.The goal of this guide is to provide insight and ideas to merge the innovative ecosystem of wellness products and medical device AI technology to suit all populations and deliver basic health technology to those who need it. The intended audiences for this toolkit are organizations working to develop AI tools for public health, as well as groups investing in the development of these tools for low–resource settings.